Objectives Stereotactic body radiotherapy is an effective treatment for patients with early-
stage non–small cell lung cancer who are not healthy enough to undergo surgery; however …

Evidence supports stereotactic body radiotherapy (SBRT) as a curative treatment option for
inoperable early stage non-small-cell lung cancer (NSCLC) resulting in high rates of tumour …

Purpose Stereotactic body radiation therapy (SBRT) is the standard of care for medically
inoperable patients with early-stage NSCLC. However, NSCLC is composed of several …

Stereotactic body radiotherapy (SBRT) has become a standard treatment option for early
stage, node negative non-small cell lung cancer (NSCLC) in patients who are either …

Introduction Surgery is the standard treatment for early stage non–small-cell lung cancer
(NSCLC). For medically inoperable patients, stereotactic ablative radiotherapy (SABR) has …

Background Clinical decision-making for patients with stage I lung cancer is complex. It
involves multiple options [lobectomy, segmentectomy, wedge, stereotactic body …

Objectives To compare cancer specific survival after thoracoscopic sublobar lung resection
and stereotactic ablative radiotherapy (SABR) for tumors≤ 2 cm in size and thoracoscopic …

BACKGROUND Stereotactic body radiation therapy (SBRT) has demonstrated high rates of
local control with low morbidity and has now emerged as the standard of care for medically …

The average lifelong rate of developing a new primary lung cancer approximates 1% and
6% per year after radical therapy for non–small-cell lung cancer and small cell lung cancer …

Introduction The relative roles of surgery and stereotactic body radiation therapy in stage I
non–small-cell lung cancer (NSCLC) are evolving particularly for marginally operable …